HOME >> MEDICINE >> NEWS
Drug therapy significantly extends lifespan of worms

Using drugs that help eliminate oxygen radicals -- the toxic byproducts of metabolism -- scientists have extended the normal lifespan of the nematode worm C. elegans by approximately 50 percent. In addition, the scientists restored a normal lifespan to mutant worms that had a mitochondrial defect causing increased oxygen radical production and rapid aging. The findings were reported in the September 1, 2000 issue of Science.

The collaborative research was conducted by Simon Melov, Ph.D., of the Buck Center for Research in Aging and formerly of the Center for Molecular Medicine at Emory University; Gordon Lithgow, Ph.D., University of Manchester, UK; Douglas Wallace, Ph.D., director of the Center for Molecular Medicine at Emory University; and Susan Doctrow, Ph.D. and Bernard Malfroy, Ph.D. of Eukarion, Inc., a biopharmaceutical company.

The drugs used in the experiments are synthetic forms of superoxide dismutase and catalase -- enzymes that naturally help control oxidative stress. Although they have an anti-oxidant effect, the compounds are much more powerful than simple anti-oxidants such as vitamin E, which eliminate individual oxygen radical molecules one-on-one and quickly lose their effectiveness. The new synthetic compounds are catalytic drugs that convert oxygen radicals to water, then reconstitute themselves in a cogwheel-like process that continues to destroy additional oxygen radicals as long as the drugs remain in the body.

Since the early 1970s, Dr. Wallace and his colleagues in Emory's Center for Molecular Medicine have been studying mitochondria -- the tiny power plants located in the cytoplasm of cells. Dr. Wallace believes that by demonstrating the effectiveness of these drugs in slowing the aging process, this work supports his long-held hypothesis that oxygen radicals generated in the mitochondria during metabolism are a major cause of degenerative diseases and aging.

As byproducts of energy generation, says Dr. Wal
'"/>

Contact: Holly Korschun
hkorsch@emory.edu
404-727-3990
Emory University Health Sciences Center
31-Aug-2000


Page: 1 2

Related medicine news :

1. Study shows patch therapy may be as effective as oral medications
2. Novel therapy tested in mice could chase away cat allergies
3. Drug therapy may be comparable to invasive cardiac procedures for elderly patients with heart attack
4. Risk of cardiac death after radiotherapy for breast cancer has declined, study finds
5. Antiretroviral therapy may prevent excess risk of some cancers in people with HIV
6. Bevacizumab combined with chemotherapy prolongs survival for some patients with advanced lung cancer
7. Breakthrough in medical research: New chemotherapy gives hope to brain tumour patients
8. Two years after gene therapy treatments, severe angina patients showed prolonged clinical benefit
9. Combining PET and CT scans leads to more accurate radiation therapy for lung cancer patients
10. Cognitive behavioral therapy and medication is effective in the treatment of panic disorder
11. Study finds drug eluting stents as effective as vascular brachytherapy in preventing restenosis

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Drug therapy significantly extends lifespan worms

(Date:7/31/2014)... Thousands of independent community pharmacists, industry ... come together today to kick off ThoughtSpot 2014, ... "ThoughtSpot 2014 is Good Neighbor Pharmacy’s annual conference ... help their businesses thrive," stated AJ Caffentzis, President, ... commitment to independent community pharmacies, and at ThoughtSpot, ...
(Date:7/31/2014)... San Francisco, California (PRWEB) July 31, 2014 ... systems is expected to reach USD 37.83 billion ... Grand View Research, Inc. Increasing geriatric population base ... such as cardiovascular, orthopedic, and respiratory diseases coupled ... drive market growth over the next six years. ...
(Date:7/31/2014)... By Steven Reinberg ... (HealthDay News) -- Strict regulation of electronic cigarettes isn,t ... says. On the contrary, allowing e-cigarettes to compete ... the researchers concluded after reviewing 81 prior studies on ... "Current evidence suggests that there is a ...
(Date:7/31/2014)... (PRWEB) July 31, 2014 ... to reach $702m by 2020, increasing slowly ... market will be driven by: the rising ... incurred by government agencies, such as Medicare, ... adoption of innovative technologies such as flow ...
(Date:7/31/2014)... for those with periodontal disease related to type 2 diabetes, ... report appearing in the August 2014 issue of the ... most important blood cells involved in the human immune response, ... in type 2 diabetes-associated periodontal disease. These findings support ... cells may treat or prevent this complication. , "Our ...
Breaking Medicine News(10 mins):Health News:Good Neighbor Pharmacy’s ThoughtSpot Begins Today with Record Attendance 2Health News:Good Neighbor Pharmacy’s ThoughtSpot Begins Today with Record Attendance 3Health News:Medical Imaging Systems - Global Industry Trends, Size, Share, Opportunity, Growth, Outlook, Segmentation and Forecast from 2014 to 2020 - Grand View Research, Inc. 2Health News:Medical Imaging Systems - Global Industry Trends, Size, Share, Opportunity, Growth, Outlook, Segmentation and Forecast from 2014 to 2020 - Grand View Research, Inc. 3Health News:Medical Imaging Systems - Global Industry Trends, Size, Share, Opportunity, Growth, Outlook, Segmentation and Forecast from 2014 to 2020 - Grand View Research, Inc. 4Health News:Medical Imaging Systems - Global Industry Trends, Size, Share, Opportunity, Growth, Outlook, Segmentation and Forecast from 2014 to 2020 - Grand View Research, Inc. 5Health News:Medical Imaging Systems - Global Industry Trends, Size, Share, Opportunity, Growth, Outlook, Segmentation and Forecast from 2014 to 2020 - Grand View Research, Inc. 6Health News:Benefits of E-Cigarettes May Outweigh Harms, Study Finds 2Health News:Benefits of E-Cigarettes May Outweigh Harms, Study Finds 3Health News:US Neurovascular Interventions Market Worth $702m by 2020 Says a New Report Available at MarketOptimizer.org 2Health News:US Neurovascular Interventions Market Worth $702m by 2020 Says a New Report Available at MarketOptimizer.org 3Health News:US Neurovascular Interventions Market Worth $702m by 2020 Says a New Report Available at MarketOptimizer.org 4Health News:US Neurovascular Interventions Market Worth $702m by 2020 Says a New Report Available at MarketOptimizer.org 5Health News:Researchers uncover cause of gum disease related to type 2 diabetes 2
(Date:7/31/2014)... NOTTINGHAM, England , July 31, 2014 /PRNewswire/ ... ) today announced that its subsidiary, Molecular Profiles ... that will support pharmaceutical and biotech drug developers ... Profiles, pharmaceutical development services will be supported by ... (DMPK) to give clients a smarter route into ...
(Date:7/31/2014)... RESEARCH TRIANGLE PARK, N.C. , July 31, 2014 ... Miami facilities to meet the ... Latin America .  The newly expanded facility will ... biological samples, consolidation of shipments to and from the ... In its newest location, Marken will combine its ...
(Date:7/31/2014)... , July 31, 2014  Today,s Consumer Reports ... as an important reminder for consumers of the ... importance of initiatives such as the Acetaminophen Awareness ... consumer education campaign. Formed in 2010, the ... provider and consumer organizations dedicated to educating consumers ...
Breaking Medicine Technology:Columbia Laboratories' Subsidiary, Molecular Profiles, Strikes Alliance With Xenogesis 2Columbia Laboratories' Subsidiary, Molecular Profiles, Strikes Alliance With Xenogesis 3Marken Expands Miami Regional Logistics Center 2U.S. Health Coalition Calls for Continued Education on Acetaminophen, America's Most Common Drug Ingredient 2
Cached News: